Citations

Clear

3138 citation(s) found for "Smith, AM".

Delayed-Release Oral Mesalamine 4.8 g/day (800 mg tablets) Compared with 2.4 g/day (400 mg tablets) for the Treatment of Mildly to Moderately Active Ulcerative Colitis: The ASCEND I Trial
Hanauer, Stephen B., Sandborn, William J. , Dallaire, Christian, Archambault, André, Yacyshyn, Bruce , Yeh, Chyon, Smith-Hall, Nancy

Mayo Clinic

Canadian Journal of Gastroenterology | March 15, 2016 | Volume: 21 | Issue: 12 | Pages: 827-834

10.1155/2007/862917 | PMID 18080055 Get It

BACKGROUND: Delayed-release oral mesalamine 2.4 g/day to 4.8 g/day has been shown to be effective in treating mildly to moderately active ulcerative colitis (UC), but it is unknown whether an initial dose of 4.8 g/day is more effective than 2.4 g/day in patients with mildly to moderately active UC and in the subgroup with moderate disease.PATIENTS AND METHODS: A six-week, multicentre, randomized, double-blind, controlled trial assessing the safety and clinical efficacy of a new dose (ASCEND I) of medication randomly assigned 301 adults with mildly to moderately active UC to delayed-release oral mesalamine 2.4 g/day (400 mg tablet [n=154]) or 4.8 g/day (800 mg tablet [n=147]). The primary efficacy end point was overall improvement (ie, treatment success), defined as complete remission or response to therapy from baseline to week 6. Primary safety end points were adverse events and laboratory evaluations. Data were also analyzed separately for the prespecified subgroup of patients with moderate UC at baseline.RESULTS: Treatment success was not statistically different between the treatment groups at week 6; 51% of the group (77 of 150) who received delayed-release oral mesalamine 2.4 g/day and 56% of the group (76 of 136) who received 4.8 g/day reached the efficacy end point (P=0.441). Among the moderate disease subgroup, however, the higher initial dose was more effective; 57% of patients (53 of 93) given delayed-release oral mesalamine 2.4 g/day and 72% of patients (55 of 76) given 4.8 g/day achieved treatment success (P=0.0384). Both regimens were well tolerated.CONCLUSIONS: Delayed-release oral mesalamine is an effective and well-tolerated initial therapy in patients with mildly to moderately active UC, and a 4.8 g/day dose may enhance treatment success rates in patients with moderate disease compared with mesalamine 2.4 g/day.
Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells
Ding, Xiwei , Chaiteerakij, Roongruedee , Moser, Catherine D., Shaleh, Hassan M., Boakye, Jeffrey, Ndzengue, Albert, Zhou, Yanling , Huang, Shengbing, Thomas, Melanie B., Smith, Charles D. , Roberts, Lewis R. , Shaleh, Hassan, Chen, Gang , Chaiteerakij, Roongruedee , Li, Ying , Sinicrope, Frank A. , Zou, Xiaoping , Roberts, Lewis R

Mayo Clinic

Oncotarget | March 4, 2016 | Volume: 7 | Issue: 15 | Pages: 20080-20092

10.18632/oncotarget.7914 | PMID 26956050 Get It

Ureteroarterial Fistulas After Robotic and Open Radical Cystectomy
Palmerola, Ricardo, Westerman, Mary E. , Fakhoury, Mathew, Boorjian, Stephen A. , Richstone, Lee, Westerman, Mary E

Mayo Clinic

Journal of Endourology Case Reports | March 3, 2016 | Volume: 2 | Issue: 1 | Pages: 48-51

10.1089/cren.2015.0034 | PMID 27579415 Get It

Ureteroarterial fistulas (UAFs) are defined as an abnormal communication between one of the major arteries and the ureter. Urologists most frequently encounter iatrogenic fistulas occurring in patients with a history of pelvic extirpative surgery, chronic ureteral catheterization, and history of pelvic radiation. We present two cases of UAFs in patients with no history of prior radiation, who underwent open radical cystectomy and robot-assisted radical cystectomy with intracorporeal ileal conduit. Both patients developed postoperative ureteroileal anastomotic leaks that were managed with indwelling ureteral catheters. Furthermore, both patients were having left-sided UAF after presenting with nonlife threatening gross hematuria, which became brisk and pulsatile during ureteral stent exchange. Endovascular stenting was performed in both patients with resolution of hemorrhage and full recovery. In one patient, nephrostomy tubes were placed and ureteral catheters were removed; the second patient was managed with continued ureteral catheterization without further episodes of hematuria.
Important Skills for Internship and the Fourth-Year Medical School Courses to Acquire Them: A National Survey of Internal Medicine Residents
Pereira, Anne G. , Harrell, Heather, Weissman, Arlene, Smith, Cynthia D. , Dupras, Denise M. , Kane, Gregory C.

Mayo Clinic

Academic Medicine | March 2, 2016 | Volume: 91 | Issue: 6 | Pages: 821-826

10.1097/acm.0000000000001134 | PMID 26934691 Get It

Purpose To obtain feedback from internal medicine residents, a key stakeholder group, regarding both the skills needed for internship and the fourth-year medical school courses that prepared them for residency. This feedback could inform fourth-year curriculum redesign efforts. Method All internal medicine residents taking the 2013–2014 Internal Medicine In-Training Examination were asked to rank the importance of learning 10 predefined skills prior to internship and to use a dropdown menu of 11 common fourth-year courses to rank the 3 most helpful in preparing for internship. The predefined skills were chosen based on a review of the literature, a national subinternship curriculum, and expert consensus. Chi-square statistics were used to test for differences in responses between training levels. Results Of the 24,820 internal medicine residents who completed the exam, 20,484 (83%) completed the survey, had complete identification numbers, and consented to have their responses used for research. The three skills most frequently rated as very important were identifying when to seek additional help and expertise, prioritizing clinical tasks and managing time efficiently, and communicating with other providers around care transitions. The subinternship/acting internship was most often selected as being the most helpful course in preparing for internship. Conclusions These findings indicate which skills and fourth-year medical school courses internal medicine residents found most helpful in preparing for internship and confirm the findings of prior studies highlighting the perceived value of subinternships. Internal medicine residents and medical educators agree on the skills students should learn prior to internship.
Update on Pulmonary Fibrosis: Not All Fibrosis Is Created Equally
Smith, Maxwell L.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 29, 2016 | Volume: 140 | Issue: 3 | Pages: 221-229

10.5858/arpa.2015-0288-sa | PMID 26927716 Get It

Context Three distinct patterns of pulmonary fibrosis, including usual interstitial pneumonia, fibrotic nonspecific interstitial pneumonia, and airway-centered fibrosis, can be identified on surgical lung biopsies. Objectives To compare the pathologic definitions, clinical and radiographic presentations, etiologies and differential diagnoses, treatments, and prognoses of usual interstitial pneumonia, fibrotic nonspecific interstitial pneumonia, and airway-centered fibrosis patterns, and to address the challenges and controversies related to pulmonary fibrosis. Data Sources Data were derived from published literature and clinical experience. Conclusions Although there may be overlap, identification of the dominant form of fibrosis in a particular case can provide a general category of disease and assist in identifying an etiology.
Current practices for treatment of respiratory syncytial virus and other non‐influenza respiratory viruses in high‐risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative
Freifeld, Alison G. , Ison, Michael G. , Lawrence, Steven J., Theodoropoulos, Nicole , Clark, Nina M. , Alangaden, George , Miller, Rachel , Young, Jo‐Anne H. , Hawkinson, Dana, Pursell, Kenneth, Ison, M G , Beaird, Omer Eugene , Razonable, Raymund R. , Smith, Jeannina A. , Kaul, Daniel R. , Young, Jo-Anne H

Mayo Clinic

Transplant Infectious Disease | February 29, 2016 | Volume: 18 | Issue: 2 | Pages: 210-215

10.1111/tid.12510 | PMID 26923867 Get It

AbstractBackgroundThe optimal treatment for respiratory syncytial virus (RSV) infection in adult immunocompromised patients is unknown. We assessed the management of RSV and other non‐influenza respiratory viruses in Midwestern transplant centers.MethodsA survey assessing strategies for RSV and other non‐influenza respiratory viral infections was sent to 13 centers.ResultsMultiplex polymerase chain reaction assay was used for diagnosis in 11/12 centers. Eight of 12 centers used inhaled ribavirin (RBV) in some patient populations. Barriers included cost, safety, lack of evidence, and inconvenience. Six of 12 used intravenous immunoglobulin (IVIG), mostly in combination with RBV. Inhaled RBV was used more than oral, and in the post‐stem cell transplant population, patients with lower respiratory tract infection (LRTI), graft‐versus‐host disease, and more recent transplantation were treated at higher rates. Ten centers had experience with lung transplant patients; all used either oral or inhaled RBV for LRTI, 6/10 treated upper respiratory tract infection (URTI). No center treated non‐lung solid organ transplant (SOT) recipients with URTI; 7/11 would use oral or inhaled RBV in the same group with LRTI. Patients with hematologic malignancy without hematopoietic stem cell transplantation were treated with RBV at a similar frequency to non‐lung SOT recipients. Three of 12 centers, in severe cases, treated parainfluenza and metapneumovirus, and 1/12 treated coronavirus.ConclusionsTreatment of RSV in immunocompromised patients varied greatly. While most centers treat LRTI, treatment of URTI was variable. No consensus was found regarding the use of oral versus inhaled RBV, or the use of IVIG. The presence of such heterogeneity demonstrates the need for further studies defining optimal treatment of RSV in immunocompromised hosts.
4EBP1/c-MYC/PUMA and NF-κB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells
Knorr, Katherine , Almada, Luciana L. , Schneider, Paula A., Peterson, Kevin L. , Flatten, Karen S., Dai, Haiming , Pratz, Keith W. , Hess, Allan D., Karp, Judith E. , Hendrickson, Andrea E. Wahner , Fernández-Zapico, Martín E. , Kaufmann, Scott H. , Yun, Seongseok , Vincelette, Nicole D. , Smith, B. Douglas , Dai, Haiming

Mayo Clinic

Blood | February 25, 2016 | Volume: 127 | Issue: 22 | Pages: 2711-2722

10.1182/blood-2015-02-629485 | PMID 26917778 Get It

Key Points Agents that inhibit both complexes containing the mammalian target of rapamycin are particularly toxic to acute lymphocytic leukemia cells. This killing reflects engagement of a 4EBP1/c-MYC/PUMA axis downstream of mTORC1 and an NF-κB/EGR1/BIM axis downstream of mTORC2.
RNA‐seq analysis of clinical‐grade osteochondral allografts reveals activation of early response genes
Yang, Lin , Lewallen, Eric A. , Camilleri, Emily T. , Bonin, Carolina A. , Jones, Dakota L. , Dudakovic, Amel , Galeano‐Garces, Catalina , Wang, Wei , Karperien, Marcel , Larson, A. Noelle , Dahm, Diane L., Levy, Bruce A. , Smith, Jay , Ryssman, Daniel B., Im, Hee‐Jeong , Wijnen, André J. van , Riester, Scott M. , Krych, Aaron J. , Camilleri, Emily , Lin, Yang , Larson, Annalise N, van Wijnen, Andre J, Stuart, Michael J. , Westendorf, Jennifer J. , van Wijnen, Andre J , Krych, Aaron J , Larson, A Noelle , Camilleri, Emily

Mayo Clinic

Journal of Orthopaedic Research | February 25, 2016 | Volume: 34 | Issue: 11 | Pages: 1950-1959

10.1002/jor.23209 | PMID 26909883 Get It

ABSTRACTPreservation of osteochondral allografts used for transplantation is critical to ensure favorable outcomes for patients after surgical treatment of cartilage defects. To study the biological effects of protocols currently used for cartilage storage, we investigated differences in gene expression between stored allograft cartilage and fresh cartilage from living donors using high throughput molecular screening strategies. We applied next generation RNA sequencing (RNA‐seq) and real‐time reverse transcription quantitative polymerase chain reaction (RT‐qPCR) to assess genome‐wide differences in mRNA expression between stored allograft cartilage and fresh cartilage tissue from living donors. Gene ontology analysis was used to characterize biological pathways associated with differentially expressed genes. Our studies establish reduced levels of mRNAs encoding cartilage related extracellular matrix (ECM) proteins (i.e., COL1A1, COL2A1, COL10A1, ACAN, DCN, HAPLN1, TNC, and COMP) in stored cartilage. These changes occur concomitantly with increased expression of “early response genes” that encode transcription factors mediating stress/cytoprotective responses (i.e., EGR1, EGR2, EGR3, MYC, FOS, FOSB, FOSL1, FOSL2, JUN, JUNB, and JUND). The elevated expression of “early response genes” and reduced levels of ECM‐related mRNAs in stored cartilage allografts suggests that tissue viability may be maintained by a cytoprotective program that reduces cell metabolic activity. These findings have potential implications for future studies focused on quality assessment and clinical optimization of osteochondral allografts used for cartilage transplantation. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:1950–1959, 2016.
Development and Validation of HealthImpact: An Incident Diabetes Prediction Model Based on Administrative Data
Nori, Vijay S. , Smith, Steven A., Hane, Christopher A. , McCoy, Rozalina G.

Mayo Clinic

Health Services Research | February 21, 2016 | Volume: 51 | Issue: 5 | Pages: 1896-1918

10.1111/1475-6773.12461 | PMID 26898782 Get It

Objective To develop and validate a model of incident type 2 diabetes based solely on administrative data. Data Sources/Study Setting Optum Labs Data Warehouse (OLDW), a national commercial administrative dataset. Study Design HealthImpact model was developed and internally validated using nested case–control study design; n = 473,049 in training cohort and n = 303,025 in internal validation cohort. HealthImpact was externally validated in 2,000,000 adults followed prospectively for 3 years. Only adults ≥18 years were included. Data Collection/Extraction Methods Patients with incident diabetes were identified using HEDIS rules. Control subjects were sampled from patients without diabetes. Medical and pharmacy claims data collected over 3 years prior to index date were used to build the model variables. Principal Findings HealthImpact, scored 0–100, has 48 variables with c‐statistic 0.80815. We identified HealthImpact threshold of 90 as identifying patients at high risk of incident diabetes. HealthImpact had excellent discrimination in external validation cohort (c‐statistic 0.8171). The sensitivity, specificity, positive predictive value, and negative predictive value of HealthImpact >90 for new diagnosis of diabetes within 3 years were 32.35, 94.92, 22.25, and 96.90 percent, respectively. Conclusions HealthImpact is an efficient and effective method of risk stratification for incident diabetes that is not predicated on patient‐provided information or laboratory tests.
Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors
Shah, Paras , Moreira, Daniel M. , Okhunov, Zhamshid , Patel, Vinay , Chopra, Sameer , Razmaria, Aria, Alom, Manaf, George, Arvin K. , Yaskiv, Oksana, Schwartz, Michael J. , Desai, Mihir , Vira, Manish , Richstone, Lee, Landman, Jaime, Shalhav, Arieh L., Gill, Inderbir S. , Kavoussi, Louis R., Gill, Inderbir S

Mayo Clinic

Journal of Urology | February 20, 2016 | Volume: 196 | Issue: 2 | Pages: 327-334

10.1016/j.juro.2016.02.075 | PMID 26907508 Get It